1. Home
  2. JPM vs AZN Comparison

JPM vs AZN Comparison

Compare JPM & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JP Morgan Chase & Co.

JPM

JP Morgan Chase & Co.

HOLD

Current Price

$311.99

Market Cap

837.0B

Sector

Finance

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$185.45

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JPM
AZN
Founded
1799
1992
Country
United States
United Kingdom
Employees
320079
96100
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
837.0B
316.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JPM
AZN
Price
$311.99
$185.45
Analyst Decision
Buy
Strong Buy
Analyst Count
15
1
Target Price
$331.93
N/A
AVG Volume (30 Days)
7.4M
1.7M
Earning Date
04-14-2026
04-29-2026
Dividend Yield
1.94%
1.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$18.51
$10.34
Revenue Next Year
$4.11
$6.43
P/E Ratio
$15.42
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$262.71
$68.62
52 Week High
$337.25
$212.71

Technical Indicators

Market Signals
Indicator
JPM
AZN
Relative Strength Index (RSI) 59.15 49.81
Support Level $294.09 $180.98
Resistance Level $315.32 $191.50
Average True Range (ATR) 5.85 3.00
MACD 1.09 -0.05
Stochastic Oscillator 84.95 61.27

Price Performance

Historical Comparison
JPM
AZN

About JPM JP Morgan Chase & Co.

JPMorgan is a leading global financial services firm with operations in 66 countries and over 318,000 employees as of year-end 2025. Under the JPMorgan brands, the bank holding company boasts a $4.9 trillion balance sheet and $2.68 trillion in deposits, as of March 2026. The firm generates its revenue across three core operating segments: consumer and community banking, the commercial and investment bank, and asset and wealth management. It maintains the top global ranking in investment banking fees with an 8.4% market share, serves millions of consumers through its network of over 5,000 US branches, and manages over $7.1 trillion in client assets within its wealth and asset management franchise.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: